Keyphrases
MicroRNA Expression
100%
Recent Advances
100%
Medullary Thyroid Carcinoma
100%
MicroRNA
28%
RET mutation
28%
Clinical Trials
14%
Regulatory Role
14%
Tumor
14%
Treatment Response
14%
Behavioral Response
14%
Germ Cells
14%
Cabozantinib
14%
Aggressive Behavior
14%
Multikinase Inhibitor
14%
Deregulation
14%
FDA-approved Drugs
14%
Prognostic Implications
14%
Lymph Node Metastasis
14%
Molecular Events
14%
Penetrance
14%
Neuroendocrine Tumor
14%
Thyroid Cancer
14%
C Cells
14%
Vandetanib
14%
Tumor Treatment
14%
Tumor Behavior
14%
Therapeutic Implications
14%
Follicular Tumor
14%
Gene Regulatory Programs
14%
Sporadic Medullary Thyroid Carcinoma
14%
Medicine and Dentistry
microRNA
100%
Thyroid Medullary Carcinoma
100%
Tumor
25%
Clinical Trial
12%
Neoplasm
12%
Regulator Gene
12%
Lymph Node Metastasis
12%
Treatment Response
12%
Neuroendocrine Tumor
12%
Thyroid Cancer
12%
Penetrance
12%
Cabozantinib
12%
Germ Cell
12%
Vandetanib
12%
Pharmacology, Toxicology and Pharmaceutical Science
microRNA
100%
Thyroid Medullary Carcinoma
100%
Clinical Trial
12%
Lymph Node Metastasis
12%
Thyroid Cancer
12%
Vandetanib
12%
Neuroendocrine Tumor
12%
Neoplasm
12%
Cabozantinib
12%